Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults with obesity or overweight with at least one weight-related condition. This guide explains how to pursue a Wegovy prescription, what clinicians consider when deciding who qualifies, how to prepare for a visit, and practical next steps grounded in current clinical standards. The information below is intended to help you have an informed conversation with a qualified healthcare professional about whether this option fits your health goals and circumstances.
What Wegovy Is and How It Works
Wegovy contains semaglutide 2.4 mg, a higher dose than the version used for type 2 diabetes. Semaglutide mimics a hormone that regulates appetite and food intake, acting on brain regions involved in hunger and satiety. Used alongside a reduced-calorie diet and increased physical activity, it can lead to meaningful weight loss in appropriately selected patients. It is not a short-term diet pill; treatment is typically ongoing and requires medical supervision to monitor effectiveness and safety over time.
Whether You May Qualify
Clinicians generally consider Wegovy for adults who meet specific clinical criteria related to body weight and health. These criteria are based on regulatory approvals and clinical practice guidelines, and they help ensure the treatment is used safely and effectively. Meeting these criteria does not guarantee a prescription, but it defines the starting point for a clinical assessment.
Typical Eligibility Considerations
- Body mass index (BMI) of 30 kg/m² or higher (obesity) or 27 kg/m² or higher with at least one weight-related comorbidity, such as type 2 diabetes, high blood pressure, or dyslipidemia.
- In some contexts, adults with lower BMI and documented weight-related health issues may also be considered after a thorough evaluation.
- Wegovy is not suitable for people with a personal or family history of certain types of thyroid cancer or multiple endocrine neoplasia syndrome type 2.
- Women who are pregnant, planning pregnancy, or breastfeeding are generally not candidates due to potential risks to the fetus or infant.
How to Prepare for a Medical Visit
A productive visit starts with preparation. The more specific and factual information you provide, the better your clinician can assess whether Wegovy is appropriate for you and outline a safe plan. Bring objective data about your health history and current habits so the conversation can focus on medical suitability and next steps.
Information to Bring to Your Appointment
| Item | Purpose | Examples or Notes |
|---|---|---|
| Current weight and height | Calculate BMI and contextualize weight status | Recent, accurate measurements |
| List of current medications and supplements | Identify potential interactions or contraindications | Include doses and frequencies |
| Weight‑related health conditions | Assess whether criteria for use are met | Diabetes, hypertension, sleep apnea, etc. |
| Past weight loss attempts and treatments | Show what has or has not worked previously | Diets, programs, medications, surgeries |
| Questions about dosing, side effects, and monitoring | Ensure you understand expectations and risks | Practical logistics and safety concerns |
What to Expect During the Clinical Evaluation
During the visit, your clinician will review your medical history, current health status, and weight-related concerns to determine whether Wegovy aligns with your overall care plan. This assessment is not automatic; it is a clinical decision based on benefits and risks. If prescribed, you will receive instructions on dosing, administration, monitoring, and lifestyle changes that support effectiveness.
Key Points of the Evaluation
- Discussion of your weight history, health conditions, and goals.
- Review of potential benefits and known risks, including gastrointestinal side effects and rare warnings such as thyroid C-cell tumors in animal studies.
- Clarification that Wegovy is a long-term treatment option, not a quick fix, and that regular follow-up is necessary.
- Explanation of how to use the medication, including injection technique and storage guidance.
Practical Considerations and Costs
Once prescribed, using Wegovy involves practical logistics related to dosing, monitoring, and cost. Planning for these factors helps ensure continuity of therapy and reduces surprises. Insurance coverage and savings programs can significantly affect out-of-pocket expenses, so checking benefits early is important.
What to Expect After a Prescription
- Dosing typically starts low and is increased gradually under medical guidance to minimize side effects.
- Regular follow-up visits or telehealth check-ins to track progress, adjust dosing, and manage side effects.
- Potential out-of-pocket costs depending on insurance; manufacturer savings programs may be available for eligible patients.
- Laboratory tests are generally not required solely for Wegovy but may be used to monitor related conditions such as diabetes.
Insurance, Savings, and Affordability Tips
Navigating coverage for weight management medications can be complex. Many insurance plans provide some coverage for GLP-1 agonists like Wegovy, but specifics vary widely. Contacting your plan and pharmacy ahead of time can clarify copays, prior authorization requirements, and whether a medical necessity letter is needed. Manufacturer programs may lower costs for qualified individuals without adequate prescription drug coverage.
Alternatives and Complementary Approaches
Wegovy is one option among several tools for managing weight, and it works best when combined with sustainable lifestyle changes. Other approaches include dietary modification, increased physical activity, behavioral support, and, in some cases, other medications or procedures. A healthcare professional can help design a plan that matches your health status, preferences, and goals while emphasizing long-term safety and overall well-being.
When to Seek Immediate Medical Care
While uncommon, some side effects require prompt attention. If you experience symptoms such as severe abdominal pain, persistent vomiting, lightheadedness, or signs of an allergic reaction shortly after starting Wegovy, contact a healthcare professional or seek emergency services immediately. These situations are rare but important to recognize early.